Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites - PubMed (original) (raw)
Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites
T S Pillay et al. J Clin Invest. 1996.
Abstract
Elevated glucose concentrations have been reported to inhibit insulin receptor kinase activity. We studied the effects of high glucose on insulin action in Rat1 fibroblasts transfected with wild-type human insulin receptor (HIRcB) and a truncated receptor lacking the COOH-terminal 43 amino acids (delta CT). In both cell lines, 25 mM glucose impaired receptor and insulin receptor substrate-1 phosphorylation by 34%, but IGF-1 receptor phosphorylation was unaffected. Phosphatidylinositol 3-kinase activity and bromodeoxyuridine uptake were decreased by 85 and 35%, respectively. This was reversed by coincubation with a protein kinase C (PKC) inhibitor or microinjection of a PKC inhibitor peptide. Phosphopeptide mapping revealed that high glucose or PMA led to serine/threonine phosphorylation of similar peptides. Inhibition of the microtubule-associated protein (MAP) kinase cascade by the MAP kinase kinase inhibitor PD98059 did not reverse the impaired phosphorylation. We conclude that high glucose inhibits insulin action by inducing serine phosphorylation through a PKC-mediated mechanism at the level of the receptor at sites proximal to the COOH-terminal 43 amino acids. This effect is independent of activation of the MAP kinase cascade. Proportionately, the impairment of insulin receptor substrate-1 tyrosine phosphorylation is greater than that of the insulin receptor resulting in attenuated phosphatidylinositol 3-kinase activation and mitogenic signaling.
Similar articles
- Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
Usui I, Takata Y, Imamura T, Morioka H, Sasaoka T, Sawa T, Ishihara H, Ishiki M, Kobayashi M. Usui I, et al. Diabetologia. 1997 Aug;40(8):894-901. doi: 10.1007/s001250050765. Diabetologia. 1997. PMID: 9267983 - Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG, Blakesley VA, Stannard BS, LeRoith D. Scrimgeour AG, et al. Endocrinology. 1997 Jun;138(6):2552-8. doi: 10.1210/endo.138.6.5215. Endocrinology. 1997. PMID: 9165048 - A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
Almind K, Inoue G, Pedersen O, Kahn CR. Almind K, et al. J Clin Invest. 1996 Jun 1;97(11):2569-75. doi: 10.1172/JCI118705. J Clin Invest. 1996. PMID: 8647950 Free PMC article. - Insulin action in cells expressing truncated or kinase-defective insulin receptors. Dissection of multiple hormone-signaling pathways.
McClain DA. McClain DA. Diabetes Care. 1990 Mar;13(3):302-16. doi: 10.2337/diacare.13.3.302. Diabetes Care. 1990. PMID: 2155094 Review.
Cited by
- High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach.
Katsoulieris EN, Drossopoulou GI, Kotsopoulou ES, Vlahakos DV, Lianos EA, Tsilibary EC. Katsoulieris EN, et al. PLoS One. 2016 Jul 19;11(7):e0158873. doi: 10.1371/journal.pone.0158873. eCollection 2016. PLoS One. 2016. PMID: 27434075 Free PMC article. - Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K).
Maeno Y, Li Q, Park K, Rask-Madsen C, Gao B, Matsumoto M, Liu Y, Wu IH, White MF, Feener EP, King GL. Maeno Y, et al. J Biol Chem. 2012 Feb 10;287(7):4518-30. doi: 10.1074/jbc.M111.286591. Epub 2011 Dec 12. J Biol Chem. 2012. PMID: 22158866 Free PMC article. - Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.
Ohtsubo K, Chen MZ, Olefsky JM, Marth JD. Ohtsubo K, et al. Nat Med. 2011 Aug 14;17(9):1067-75. doi: 10.1038/nm.2414. Nat Med. 2011. PMID: 21841783 Free PMC article. - In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.
Chun KH, Choi KD, Lee DH, Jung Y, Henry RR, Ciaraldi TP, Kim YB. Chun KH, et al. Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E536-42. doi: 10.1152/ajpendo.00538.2010. Epub 2010 Dec 28. Am J Physiol Endocrinol Metab. 2011. PMID: 21189360 Free PMC article. - Glycogen synthase kinase 3 beta mediates high glucose-induced ubiquitination and proteasome degradation of insulin receptor substrate 1.
Leng S, Zhang W, Zheng Y, Liberman Z, Rhodes CJ, Eldar-Finkelman H, Sun XJ. Leng S, et al. J Endocrinol. 2010 Aug;206(2):171-81. doi: 10.1677/JOE-09-0456. Epub 2010 May 13. J Endocrinol. 2010. PMID: 20466847 Free PMC article.
References
- Nature. 1985 Feb 28-Mar 6;313(6005):756-61 - PubMed
- Horm Res. 1994;41 Suppl 2:51-5 - PubMed
- J Biol Chem. 1986 Mar 15;261(8):3869-75 - PubMed
- Proc Natl Acad Sci U S A. 1986 Aug;83(16):5822-4 - PubMed
- EMBO J. 1986 Oct;5(10):2503-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous